Skip to main content
Premium Trial:

Request an Annual Quote

It’s Not About Plastics Anymore


We’ve got one word for you: biochips. According to a new Frost & Sullivan report, the global market for microarrays, microfluidic devices, and other biochips will see annual growth of 65 percent and reach $3.3 billion by 2004.

More than 100 companies have already seen the microarray light, the report says. F&S predicts that segment’s revenues will hit $2.6 billion in 2004, up from estimates of $874 million this year and $232 million in 1999. The report suggests that the microarray market will be marked by ongoing patent disputes, consolidation, a trend toward higher density arrays, and more labs investing in homemade microarrays.

The microfluidics segment, which is said to be just starting, will grow to $395 million by 2004 from $17 million in 1999 and $77 million this year, according to the report. It goes on to note the spurt of alliances emerging between companies in this sector and liquid handling companies.

Other types of chips will grow too, the report says, with estimates at $311 million by 2004, up from $81 million this year. Notable growth is forecast for biochips using bioelectric detection.

Long term, F&S predicts that the sector could eventually see even more growth. “If diagnostic tests (human or otherwise) using biochips become widespread, the market for such products could reach the tens of billions by 2010,” according to the report.

— Marian Moser Jones

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.